Re-differentiation of thyroid carcinoma cell lines treated with 5-Aza-2′-deoxycytidine and retinoic acid
- 13 August 2009
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 307 (1-2) , 142-148
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Treatment with Drugs Able to Reduce Iodine Efflux Significantly Increases the Intracellular Retention Time in Thyroid Cancer Cells Stably Transfected with Sodium Iodide Symporter Complementary Deoxyribonucleic AcidThe Journal of Clinical Endocrinology & Metabolism, 2006
- A Novel Therapeutic Strategy for Medullary Thyroid Cancer Based on Radioiodine Therapy following Tissue-Specific Sodium Iodide Symporter Gene ExpressionThe Journal of Clinical Endocrinology & Metabolism, 2005
- DNA methylation disturbances as novel therapeutic target in lung cancer: Preclinical and clinical resultsCritical Reviews in Oncology/Hematology, 2005
- All-Trans-Retinoic Acid Treatment Inhibits the Growth of Retinoic Acid Receptor β Messenger Ribonucleic Acid Expressing Thyroid Cancer Cell Lines but Does Not Reinduce the Expression of Thyroid-Specific GenesThe Journal of Clinical Endocrinology & Metabolism, 2005
- Renaissance of the Biologically Active Vitamin A Derivatives: Established and Novel Directed Therapies for Cancer and ChemopreventionCurrent Pharmaceutical Design, 2003
- The Sodium/Iodide Symporter (NIS): Characterization, Regulation, and Medical SignificanceEndocrine Reviews, 2003
- Update on Intrathyroidal Iodine MetabolismThyroid®, 2001
- Up-Regulation of PTHrP and Bcl-2 Expression Characterizes the Progression of Osteochondroma towards Peripheral Chondrosarcoma and Is a Late Event in Central ChondrosarcomaLaboratory Investigation, 2000
- Retinoid differentiation therapy in promyelocytic leukemiaThe FASEB Journal, 1996
- Cellular tumorigenicity in nude mice: Correlation with cell growth in semi-solid mediumCell, 1974